Earnings per fully diluted share was $0.24 for the fourth quarter compared to $0.18 for the same quarter last year.
Adjusted earnings per fully diluted share was $0.31 per diluted share for the fourth quarter compared to $0.20 in the same quarter last year.
We expect net revenue to be in the range of $5.575 billion $5.675 billion.
And fully diluted earnings per share is expected to be in the range of $1.27 to $1.46.
Overall, our net revenue in the fourth quarter increased 8.7% to $1.37 billion.
Adjusted EBITDA is expected to be in the range of $725 million to $760 million.
Earnings per fully diluted share was $1.10 for the year compared to $1.02 last year.
Adjusted earnings per fully diluted share was $1.24 per diluted share for the year compared to $1.3 last year.
We also increased our portfolio of outpatient rehab clinics by 78 clinics during the year and in 2019 with 1,740 clinics under our management.
For the full year, net revenue increased 7.3% to $5.45 billion.
For the year, we generated $25 million in equity and earnings of unconsolidated subsidiaries.
Excluding the pre-tax losses on early retirement of debt and non-operating gains and the related tax effects this year, our adjusted earnings per share was $1.24.
Net revenue in our outpatient rehab segment for the fourth quarter increased 7.7% to $272 million compared to $252 million in the same quarter last year.
Net revenue in our rehabilitation hospital segment for the fourth quarter increased 20.9% to $380 million [Phonetic] compared to $151 million in the same quarter last year.
For the year, net revenue in our critical illness recovery hospital segment increased 4.7% to $1.84 billion.
Net revenue in our critical illness recovery hospital segment in the fourth quarter increased 6.7% to $455 million.